摘要
目的探讨阿莫西林联合果胶铋治疗慢性萎缩性胃炎的临床效果。方法将151例慢性萎缩性胃炎患者分为实验组和对照组,实验组(76例)给予阿莫西林联合果胶铋治疗,对照组(75例)给予克拉霉素联合果胶铋治疗,比较两组的临床疗效及不良反应。结果实验组总有效率为96.05%,对照组总有效率为74.67%,两组差异有统计学意义(P<0.05);实验组不良反应发生率为7.89%,对照组不良反应发生率为9.33%,两组差异无统计学意义(P>0.05)。结论阿莫西林联合果胶铋治疗慢性萎缩性胃炎,可提高疗效,降低不良反应发生率。
Objective To observe the clinical effect of amoxicillin combined with colloidal bismuth pectin in the treat- ment of chronic atrophic gastritis.Methods 151 cases of patients with chronic atrophic gastritis were selected and divid- ed into experiment group and control group.The experiment group （76 cases） were treated with amoxicillin combined with colloidal bismuth pectin,and the control group （75 cases） were treated with clarithromyein combined with colloidal bismuth pectin.The clinical efficacy and adverse reactions was compared between two groups.Results The total effective rate of the experiment group was 96.05%,the control group was 74.67%,the difference was significant （P〈0.05）.The inci- dence rate of adverse reactions was 7.89%,the control group was 9.33%,the difference was not significant （P〉0.05）. Conclusion Amoxicillin combined with colloidal bismuth pectin treating chronic atrophic gastritis can improve the total effective rate and reduce the adverse reactions.
出处
《中国当代医药》
2014年第12期89-90,共2页
China Modern Medicine
关键词
慢性萎缩性胃炎
阿莫西林
果胶铋
Chronic atrophic gastritis
Amoxicillin
Colloidal bismuth pectin
